Alere Inc of the US, a provider of point-of-care diagnostics for chronic disease, is shedding some of its non-core assets by spinning them off into a newly formed company that is to be listed on the London Stock Exchange. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
